Skip Navigation


International Immunology Advance Access originally published online on May 20, 2005
International Immunology 2005 17(7):889-897; doi:10.1093/intimm/dxh268
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/7/889    most recent
dxh268v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Takeda, A.
Right arrow Articles by Yoshida, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeda, A.
Right arrow Articles by Yoshida, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2005. All rights reserved. For permissions, please e-mail: journals.permissions@oupjournals.org

WSX-1 over-expression in CD4+ T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation

Atsunobu Takeda1,2, Shinjiro Hamano3, Hiroshi Shiraishi1, Takeru Yoshimura1,2, Hisanobu Ogata1, Kazunari Ishii3, Tatsuro Ishibashi2, Akihiko Yoshimura1 and Hiroki Yoshida1,4,5

1 Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, 2 Department of Ophthalmology and 3 Department of Parasitology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
4 PRESTO, Japan Science and Technology Corporation (JST), Kawaguchi, Saitama 332-0012, Japan
5 Department of Biomolecular Sciences, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan

Correspondence to: H. Yoshida; E-mail: yoshidah{at}med.saga-u.ac.jp.

WSX-1 is a component of the IL-27R. Analyses of WSX-1 knockout (WSX-1–/–) mice have shown that IL-27/WSX-1 signaling is essential for the proper development of Th1 responses and that WSX-1 can suppress cellular activation and pro-inflammatory cytokine production. We have generated transgenic mouse lines over-expressing the WSX-1 gene under the control of the T cell-specific CD2 promoter (WSX-1 Tg mice). Unexpectedly, like activated CD4+ T cells from WSX-1–/– mice, activated CD4+ T cells from WSX-1 Tg mice showed increased proliferation, augmented IL-2 production and up-regulated surface expression of activation markers. IL-27-mediated tyrosine phosphorylation of STAT1 was also enhanced in WSX-1 Tg CD4+ T cells, but STAT3 activation was normal. Exogenous IL-27 supported the proliferation of wild-type CD4+ T cells but suppressed that of WSX-1 Tg cells. WSX-1 over-expression increased IFN-{gamma} production in Th1-polarized CD4+ T cells, but also promoted Th2 cytokine production under Th1-polarizing conditions. Importantly, WSX-1 over-expression failed to suppress Th2 cytokine production under Th2-polarizing conditions. Cytokine hyperproduction was also observed in vivo in WSX-1 Tg mice injected with Con A. Our data suggest that WSX-1 plays a pivotal role in regulating T cell responsiveness to TCR stimulation and that the correct balance of STAT1/STAT3 activation downstream of IL-27R engagement is crucial for the physiological function of IL-27.

Keywords: CD4, cytokine, IL-27, transgene

Transmitting editor: T. Watanabe


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
N Sugiyama, H Nakashima, T Yoshimura, A Sadanaga, S Shimizu, K Masutani, T Igawa, M Akahoshi, K Miyake, A Takeda, et al.
Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor {alpha} (WSX-1)
Ann Rheum Dis, October 1, 2008; 67(10): 1461 - 1467.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Pradhan, Q. T. Lambert, and G. W. Reuther
Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor
PNAS, November 20, 2007; 104(47): 18502 - 18507.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Brender, G. M. Tannahill, B. J. Jenkins, J. Fletcher, R. Columbus, C. J. M. Saris, M. Ernst, N. A. Nicola, D. J. Hilton, W. S. Alexander, et al.
Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27
Blood, October 1, 2007; 110(7): 2528 - 2536.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.